variety of different business models. The IOSCO CRA Code does not indicate a preference for one business model over another, nor are the measures described herein designed to be used only by CRAs with large
change of scoring criteria effective this year despite an increase of average number of registered patients to 176,554 from 164,812 person yoy. Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9
the following details. Financial performance Statement of income Consolidated financial statements for the 9-month ended 30 September 2017 30 September 2018 Change (Reviewed/Restated) (Reviewed
million baht and the total non-performing debt portfolio value at the end of Q2/2020 is 189,156 million baht. It is the number one leader in the country's non-performing debt portfolio in unsecured debt
Balance by Quarter Change Q3-24 Q2-24 Q3-23 Q3-24 VS Q2-24 Q3-24 VS Q3-23 (Million Baht: MB) (MB) % (MB) % Total revenue 1,926.4 1,866.9 1,704.9 59.5 3.2 221.5 13.0 Total operating expenses 1,738.9 1,698.2
loss per share of THB 3. 49. The Company’s performance of each business group as follow: Note: Operating EBITDA is EBITDA excluding Inventory Gain/Loss (net NRV), one-time item and Gain/(Loss) from
take effect as of the date when an approval is granted, but the 2-year period shall begin as from the 1st day of January of the following year. In case an approval to be which one of investment analyst
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
Maturity * March 2018 December 2017 March 2017 Change (%) Amount Portion Amount Portion Amount Portion December 2017 March 2017 Up to one year 81,259 15.5% 71,982 12.1% 88,365 16.8% 12.9% (8.0)% Between one
change in the first half of this year as well as increasing number of beds in service. Operation : Consolidated Profit & Loss Statement 4Q 4Q % 12 mth 12 mth % Unit : THB million 2018 2017 change 2018 2017